NABL accreditation is a formal recognition of the technical competence of a testing, calibration or medical laboratory for a specific task following ISO/IEC 17025:2005, ISO 15189:2007 Standards
Source: http://www.nabl-india.org/
Wednesday, November 24, 2010
National Board of Examinations
The National Board of Examinations was established in 1975 with the prime objective of improving the quality of the Medical Education by elevating the level and establishing standards of post graduate examinations in modern medicine on an all India basis.
Source:http://www.natboard.edu.in/
Source:http://www.natboard.edu.in/
Monday, November 22, 2010
Goa Medical College & Hospital
The ‘Escola Medico Cirurgica da Goa’ was established in 1842 during the Portuguese rule and renamed as Goa Medical College in 1963. It is the oldest medical college in Asia. The college is under the Goa University since 1986 before which it was under the Bombay University.
Goa Medical College & Hospital which now has its headquarters in Bambolim has a long tradition of providing quality services to all sections of the society. The Institute of Psychiatry and Human Behaviour (Bambolim), the TB and Chest Disease Hospital (St. Inez), The Rural Health and Training Centre (Mandur) and the Urban Health Centre (St. Cruz) form part of the establishment.
The Medical College besides striving to achieve excellence in patient care, has been instrumental in training a large number of medical professionals who are providing yeomen services to the people in Goa and other parts of India and all over the world.
Source:http://www.gmcmec.gov.in/
Goa Medical College & Hospital which now has its headquarters in Bambolim has a long tradition of providing quality services to all sections of the society. The Institute of Psychiatry and Human Behaviour (Bambolim), the TB and Chest Disease Hospital (St. Inez), The Rural Health and Training Centre (Mandur) and the Urban Health Centre (St. Cruz) form part of the establishment.
The Medical College besides striving to achieve excellence in patient care, has been instrumental in training a large number of medical professionals who are providing yeomen services to the people in Goa and other parts of India and all over the world.
Source:http://www.gmcmec.gov.in/
Central Council of Indian Medicine
The Central Council of Indian Medicine is the statutory body constituted under the Indian Medicine Central Council Act, 1970 vide gazette notifaction extraordinary part (ii) section 3(ii) dated 10.8.71.
Since its establishment in 1971, the Central Council has been framing on and implementing various regulations including the Curricula and Syllabii in Indian Systems of Medicine viz. Ayurved, Siddha and Unani Tibb at Under-graduate and Post-graduate level
Source: http://www.ccimindia.org/
Since its establishment in 1971, the Central Council has been framing on and implementing various regulations including the Curricula and Syllabii in Indian Systems of Medicine viz. Ayurved, Siddha and Unani Tibb at Under-graduate and Post-graduate level
Source: http://www.ccimindia.org/
Indian Systems of Medicine and Homoeopathy
The Indian Systems of Medicine and Homoeopathy (External website that opens in a new window) (ISM&H) were given an independent identity in the Ministry of Health and Family Welfare in 1995 by creating a separate Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (External website that opens in a new window) (AYUSH) in November 2003. The department is entrusted with the responsibility of developing and propagating officially recognised systems, namely, Ayurveda, Yoga, Naturopathy Siddha, Unani, and Homoeopathy. This was done in explicit realisation of contributions these ancient and holistic systems can make towards the health care of the people. These systems have marked superiority in addressing chronic conditions and offer a package of promotive and preventive interventions.
Source: http://india.gov.in/sectors/health_family/ayush.php
Source: http://india.gov.in/sectors/health_family/ayush.php
Indian Systems of Medicine and Homoeopathy (ISM&H)
Department of Indian Systems of Medicine and Homoeopathy (ISM&H) was created in March,1995 and re-named as Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) in November, 2003 with a view to providing focused attention to development of Education & Research in Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy systems. The Department continued to lay emphasis on upgradation of AYUSH educational standards, quality control and standardization of drugs, improving the availability of medicinal plant material, research and development and awareness generation about the efficacy of the systems domestically and internationally
Source :http://indianmedicine.nic.in/
Source :http://indianmedicine.nic.in/
Saturday, November 20, 2010
First Medical College and Hospital In Asia
From the age of Charak and Sushruta, i.e. Indian Medicine, to the modern allopathic treatment, Medical College and Hospital Kolkata has been serving the community of West Bengal and the neighbouring states of India.It is a center of excellence for the medical studies in undergraduate and postgraduate level and also in rendering specialized hospital services to the common people. It was established in 1835
http://www.medicalcollegekolkata.org/
http://www.medicalcollegekolkata.org/
Centers for Disease Control and Prevention (CDC)
The CDC is one of the major operating components of the Department of Health and Human Services, USA. CDC′s Mission is to collaborate to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats.
Available at: http://www.cdc.gov/
Available at: http://www.cdc.gov/
Wednesday, November 17, 2010
Library Website gives the visibility
Time to learn from leading institutes' library website just like
Cushing and Whitney Medical Library of Yale University
http://www.med.yale.edu/library/
Arizona Health Sciences Library of University of Arizona
http://www.ahsl.arizona.edu/
Welch Medical Library of Johns Hopkins University
http://www.welch.jhu.edu/
Health Sciences and Human Services Library at University of Maryland,
http://www.hshsl.umaryland.edu/
Medical College of Wisconsin Libraries
http://www.mcw.edu/mcwlibraries.htm
Cushing and Whitney Medical Library of Yale University
http://www.med.yale.edu/library/
Arizona Health Sciences Library of University of Arizona
http://www.ahsl.arizona.edu/
Welch Medical Library of Johns Hopkins University
http://www.welch.jhu.edu/
Health Sciences and Human Services Library at University of Maryland,
http://www.hshsl.umaryland.edu/
Medical College of Wisconsin Libraries
http://www.mcw.edu/mcwlibraries.htm
Medical / Health Sciences Libraries on the Web
Following link gives the list of medical libraries
http://www.lib.uiowa.edu/hardin/hslibs.html
http://www.lib.uiowa.edu/hardin/hslibs.html
'Malaria vaccine in final trials'
MUMBAI: Traditionally Big Pharma has invested and relied on blockbuster drugs, and has not been too keen on research in neglected diseases. But now the scenario may be changing with some companies like GlaxoSmithKline looking at it as a possible strategy for growth in emerging markets, which are growing at a much faster rate (mostly in double digits) as against the developed regions. GlaxoSmithKline, which has blockbusters like respiratory medicines Advair and Avamys, plans to invest around £12m per year (from 2012) in its albendazole drug programme for treating children with intestinal worms in Africa and India.
Read more: 'Malaria vaccine in final trials' - The Times of India http://timesofindia.indiatimes.com/business/india-business/Malaria-vaccine-in-final-trials/articleshow/6938098.cms#ixzz15VIGV7ry
Read more: 'Malaria vaccine in final trials' - The Times of India http://timesofindia.indiatimes.com/business/india-business/Malaria-vaccine-in-final-trials/articleshow/6938098.cms#ixzz15VIGV7ry
Bihar, UP women have highest fertility rate
Kounteya Sinha, TNN, Nov 17, 2010, 04.20am IST
NEW DELHI: Women in Bihar and Uttar Pradesh have the highest fertility rate (TFR) in India while those in Kerala and Tamil Nadu have the lowest. While the TFR in Bihar is 3.9 and that in UP is 3.8, the number stands at 1.7 in Kerala and TN.
The other states with high TFR include MP and Rajasthan at 3.3, Jharkhand at 3.2 and Chhattisgarh at 3. Assam's TFR is 2.6, Gujarat and Haryana's 2.5, Orissa's 2.4 and Jammu and Kashmir's 2.2. States with TFR between 1-2 include Delhi, Maharashtra and Karnataka at 2 and West Bengal and Punjab at 1.9.
The total fertility rate (TFR) of a population is the average number of children that would be born to a woman over her lifetime.
According to health minister Ghulam Nabi Azad, the TFR for India fell from 3.3 to 2.58 in 2008, population growth rate from 1.5% to 1.1% in 2008 and contraceptive prevalence increased to 62.3%.
India's swelling population has the health ministry seriously worried. According to Azad, unless the rapid growth of population is contained, it will be difficult to ensure quality education, healthcare, food, housing, clean drinking water, sanitation, hygiene and a healthy environment for all.
Addressing the conference of Asian Population Association on Tuesday, Azad said the sheer pressure of numbers and limited resources like land leads to widespread displacement of people forcing them to migrate in search of livelihood.
Source: http://timesofindia.indiatimes.com/
NEW DELHI: Women in Bihar and Uttar Pradesh have the highest fertility rate (TFR) in India while those in Kerala and Tamil Nadu have the lowest. While the TFR in Bihar is 3.9 and that in UP is 3.8, the number stands at 1.7 in Kerala and TN.
The other states with high TFR include MP and Rajasthan at 3.3, Jharkhand at 3.2 and Chhattisgarh at 3. Assam's TFR is 2.6, Gujarat and Haryana's 2.5, Orissa's 2.4 and Jammu and Kashmir's 2.2. States with TFR between 1-2 include Delhi, Maharashtra and Karnataka at 2 and West Bengal and Punjab at 1.9.
The total fertility rate (TFR) of a population is the average number of children that would be born to a woman over her lifetime.
According to health minister Ghulam Nabi Azad, the TFR for India fell from 3.3 to 2.58 in 2008, population growth rate from 1.5% to 1.1% in 2008 and contraceptive prevalence increased to 62.3%.
India's swelling population has the health ministry seriously worried. According to Azad, unless the rapid growth of population is contained, it will be difficult to ensure quality education, healthcare, food, housing, clean drinking water, sanitation, hygiene and a healthy environment for all.
Addressing the conference of Asian Population Association on Tuesday, Azad said the sheer pressure of numbers and limited resources like land leads to widespread displacement of people forcing them to migrate in search of livelihood.
Source: http://timesofindia.indiatimes.com/
Injectables part of birth-control drive
Kounteya Sinha, TNN, Nov 17, 2010, 03.20am IST
NEW DELHI: In a bid to increase the basket of choice of contraceptives for women, India may introduce injectable contraceptives soon.
The Union health ministry has urged the Drug Technical Advisory Body (DTAB) to allow the use of DMPA injectable contraceptives as a part of the nationwide family planning programme.
Union health secretary K Sujatha Rao confirmed on Tuesday that DTAB is all set to approve use of DMPAs in the public sector.
"Earlier, sterilisation was the dominant choice for family planning. Now, spacing methods like condoms have taken over. We're also looking at introducing injectable contraceptives to increase options for women," Rao said.
In 1995, DTAB had approved the use of DMPA in the private sector. It had felt that the public sector wasn't equipped well enough to handle its use in a large-scale manner, and also manage its side effects.
"Fortunately, we now have enough manpower and infrastructure, thanks to the National Rural Health Mission," Rao said.
Presently, women who don't want to conceive can opt for condoms, oral pills, Copper T and sterilisation.
The injectables, which have to be administered every three months, have been found to be very effective. A conception rate as low as 0.3 per 100 women in the first year of use has been recorded when injections are regularly spaced three months apart.
The injection helps stop ovulation (release of eggs from ovaries). It thickens the cervical mucus, making it difficult for sperm to pass through. It, however, doesn't disrupt existing pregnancy. It is reversible and an injection can prevent pregnancy for three months.
However, there are a few disadvantages as well. Changes in menstrual bleeding are likely, including light spotting or bleeding. In fact, amenorrhea is a normal effect especially after the first year of use. These injections may also cause weight gain (average of 1-2 kilos each year).
Severe headache, nausea, abdominal cram, hair loss, lack of sex drive and acne in some women have also been recorded.
No wonder, many women's groups have been against injectable contraceptives. They claim that studies have shown that injectable contraceptives could lead to osteoporosis. This can have grave consequences for poor women with low bone density due to lack of access to nutritious diet.
In the case against the injectable Net En -- filed in the Supreme Court in 1986 against the Union of India, ICMR, DCGI and others by Saheli and other women's groups -- the government had admitted in 2000 during the closure of the case that mass use of Net En in the family planning programme was not advisable.
Source: http://timesofindia.indiatimes.com/
NEW DELHI: In a bid to increase the basket of choice of contraceptives for women, India may introduce injectable contraceptives soon.
The Union health ministry has urged the Drug Technical Advisory Body (DTAB) to allow the use of DMPA injectable contraceptives as a part of the nationwide family planning programme.
Union health secretary K Sujatha Rao confirmed on Tuesday that DTAB is all set to approve use of DMPAs in the public sector.
"Earlier, sterilisation was the dominant choice for family planning. Now, spacing methods like condoms have taken over. We're also looking at introducing injectable contraceptives to increase options for women," Rao said.
In 1995, DTAB had approved the use of DMPA in the private sector. It had felt that the public sector wasn't equipped well enough to handle its use in a large-scale manner, and also manage its side effects.
"Fortunately, we now have enough manpower and infrastructure, thanks to the National Rural Health Mission," Rao said.
Presently, women who don't want to conceive can opt for condoms, oral pills, Copper T and sterilisation.
The injectables, which have to be administered every three months, have been found to be very effective. A conception rate as low as 0.3 per 100 women in the first year of use has been recorded when injections are regularly spaced three months apart.
The injection helps stop ovulation (release of eggs from ovaries). It thickens the cervical mucus, making it difficult for sperm to pass through. It, however, doesn't disrupt existing pregnancy. It is reversible and an injection can prevent pregnancy for three months.
However, there are a few disadvantages as well. Changes in menstrual bleeding are likely, including light spotting or bleeding. In fact, amenorrhea is a normal effect especially after the first year of use. These injections may also cause weight gain (average of 1-2 kilos each year).
Severe headache, nausea, abdominal cram, hair loss, lack of sex drive and acne in some women have also been recorded.
No wonder, many women's groups have been against injectable contraceptives. They claim that studies have shown that injectable contraceptives could lead to osteoporosis. This can have grave consequences for poor women with low bone density due to lack of access to nutritious diet.
In the case against the injectable Net En -- filed in the Supreme Court in 1986 against the Union of India, ICMR, DCGI and others by Saheli and other women's groups -- the government had admitted in 2000 during the closure of the case that mass use of Net En in the family planning programme was not advisable.
Source: http://timesofindia.indiatimes.com/
New drug cheats cancer cells into dying
Pushpa Narayan, TNN, Nov 17, 2010, 04.30am IST
Article
CHENNAI: India will soon launch a new spectrum of cancer drugs that will enhance the effects of radiation therapy by weakening the ability of the cancer cells to fight back. The drugs, developed by the Defence Research and Development Organisation (DRDO), will work on all kinds of cancer, including complicated cases such as brain tumours and soft tissue cancer.
The therapy, experts say, will not only increase the success rates of cancer treatment by three times, but also come as a big boost to Indian medical research. Similar attempts in the West are yet to see desired results.
DRDO, after several years of clinical trials, has been able to prove that a compound, 2-Deoxyglucose (2-DG), which resembles glucose but has a slightly different chemical formula and structure, can 'confuse' and 'cheat' cancer cells to become weak. (2-DG is a glucose molecule with the 2-hydroxyl group replaced by hydrogen.)
Cancer cells spend energy in sucking glucose from the body and then derive energy from these cells. When 2-DG is infused into the body, usually 30 minutes ahead of radiation, the body cells and cancer cells spend energy in sucking glucose. But unlike glucose cells, 2-DG gives them no energy.
"The cancer cells lose energy and become incapable of gaining any. At this time if we give radiation therapy, the cancer cells will not be able to fight back. So the treatment will be effective. This also brings down the intensity of radiation and minimises the side effects," said said BS Dwarakanath, head, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences (INMAS) of DRDO.
DRDO is awaiting clearance from the Drugs Controller General of India, after which production will begin. The technology has been transferred to Dr Reddy's Laboratories.
Earlier, former scientific advisor to the defence minister and secretary M Natarajan said DRDO was also in the process of developing three bio-protectors. "These are compounds derived from berries and tulsi, which show signs of protecting normal cells when they are subjected to radiotherapy or chemotherapy in animal trials. Advanced trials will soon begin," he said.
Dwarakanath and Natarajan were talking on the sidelines of the 'International Conference on Radiation Biology — Nanotechnology, Imaging and Stem Cell Research in Radiation Oncology' at the Sri Ramachandra University. The conference is being held in association with the Indian Society for Radiation Biology.
The three-day conference will aim at minimising side-effects of radiation and enhancing the positive effects. Scientists will also discuss ways to prevent the recurrence of cancer through stem cell therapy and better drug delivery through nano technology. The programme will cover all major disciplines of radiation sciences, including physics, chemistry, biology and medicine. More than 100 experts from the US, Germany, Canada, Poland, Japan and other countries are attending the conference.
Source: http://timesofindia.indiatimes.com/
Article
CHENNAI: India will soon launch a new spectrum of cancer drugs that will enhance the effects of radiation therapy by weakening the ability of the cancer cells to fight back. The drugs, developed by the Defence Research and Development Organisation (DRDO), will work on all kinds of cancer, including complicated cases such as brain tumours and soft tissue cancer.
The therapy, experts say, will not only increase the success rates of cancer treatment by three times, but also come as a big boost to Indian medical research. Similar attempts in the West are yet to see desired results.
DRDO, after several years of clinical trials, has been able to prove that a compound, 2-Deoxyglucose (2-DG), which resembles glucose but has a slightly different chemical formula and structure, can 'confuse' and 'cheat' cancer cells to become weak. (2-DG is a glucose molecule with the 2-hydroxyl group replaced by hydrogen.)
Cancer cells spend energy in sucking glucose from the body and then derive energy from these cells. When 2-DG is infused into the body, usually 30 minutes ahead of radiation, the body cells and cancer cells spend energy in sucking glucose. But unlike glucose cells, 2-DG gives them no energy.
"The cancer cells lose energy and become incapable of gaining any. At this time if we give radiation therapy, the cancer cells will not be able to fight back. So the treatment will be effective. This also brings down the intensity of radiation and minimises the side effects," said said BS Dwarakanath, head, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences (INMAS) of DRDO.
DRDO is awaiting clearance from the Drugs Controller General of India, after which production will begin. The technology has been transferred to Dr Reddy's Laboratories.
Earlier, former scientific advisor to the defence minister and secretary M Natarajan said DRDO was also in the process of developing three bio-protectors. "These are compounds derived from berries and tulsi, which show signs of protecting normal cells when they are subjected to radiotherapy or chemotherapy in animal trials. Advanced trials will soon begin," he said.
Dwarakanath and Natarajan were talking on the sidelines of the 'International Conference on Radiation Biology — Nanotechnology, Imaging and Stem Cell Research in Radiation Oncology' at the Sri Ramachandra University. The conference is being held in association with the Indian Society for Radiation Biology.
The three-day conference will aim at minimising side-effects of radiation and enhancing the positive effects. Scientists will also discuss ways to prevent the recurrence of cancer through stem cell therapy and better drug delivery through nano technology. The programme will cover all major disciplines of radiation sciences, including physics, chemistry, biology and medicine. More than 100 experts from the US, Germany, Canada, Poland, Japan and other countries are attending the conference.
Source: http://timesofindia.indiatimes.com/
Subscribe to:
Posts (Atom)
